CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
Original article

{"a":[{"_":"Sarepta taps AbbVie, Tessera vet Severino to write Duchenne firm's next chaper","$":{"href":"/pharma/sarepta-taps-abbvie-tessera-vet-severino-write-duchenne-firms-next-chaper","hreflang":"en"}}]}

Neutral
AI Analysis

Summary

Sarepta Therapeutics announced the appointment of a new permanent CEO to replace retiring longtime chief Doug Ingram, with the new leader coming from AbbVie and Tessera backgrounds.

Importance:3/10
Sentiment:
0.10
management_changeCEO_appointmentleadership
Related Companies

Read the original article

Published by FiercePharma on July 27, 2026 11:21 AM

Read Original